Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma

被引：0
|
作者：
Jonas Ecker
Ina Oehme
Ralph Mazitschek
Andrey Korshunov
Marcel Kool
Thomas Hielscher
Judit Kiss
Florian Selt
Carina Konrad
Marco Lodrini
Hedwig E Deubzer
Andreas von Deimling
Andreas E Kulozik
Stefan M Pfister
Olaf Witt
Till Milde
机构：
[1] German Cancer Research Center (DKFZ),Clinical Cooperation Unit Pediatric Oncology (G340)
[2] Massachusetts General Hospital,Center for Systems Biology
[3] The Broad Institute of Harvard and MIT,Department of Neuropathology
[4] University Hospital Heidelberg,Clinical Cooperation Unit Neuropathology (G380)
[5] German Cancer Research Center (DKFZ),Division of Pediatric Neurooncology (B062)
[6] and German Cancer Consortium (DKTK),Division of Biostatistics (C060)
[7] German Cancer Research Center (DKFZ),Section of Pediatric Brain Tumors, Department of Pediatric Oncology, Hematology and Immunology
[8] Heidelberg,Department of Pediatric Hematology
[9] Germany,undefined
[10] and German Cancer Consortium (DKTK),undefined
[11] German Cancer Consortium (DKTK),undefined
[12] German Cancer Research Center (DKFZ),undefined
[13] University Hospital Heidelberg,undefined
[14] Oncology and Bone Marrow Transplantation,undefined
[15] Charité - University Medicine Berlin,undefined
来源：
Acta Neuropathologica Communications | / 3卷
关键词：
Medulloblastoma; HDAC; HDAC inhibitor; HDAC2; MYC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Purification and enzymatic assay of class I histone deacetylase enzymes
    Adams, Mark K.
    Banks, Charles A. S.
    Miah, Sayem
    Killer, Maxime
    Washburn, Michael P.
    POST-TRANSLATIONAL MODIFICATIONS THAT MODULATE ENZYME ACTIVITY, 2019, 626 : 23 - 40
  • [42] HDACi AND PLIK1I ACT SYNERGISTICALLY IN MYC-AMPLIFIED MEDULLOBLASTOMA
    Valinciute, Gintvile
    Ecker, Jonas
    Hielscher, Thomas
    Schmidt, Christin
    Remke, Marc
    Sigismondo, Gianluca
    Krijgsveld, Jeroen
    Pfister, Stefan
    Witt, Olaf
    Milde, Till
    NEURO-ONCOLOGY, 2019, 21 : 103 - 103
  • [43] MYC-DRIVEN UPREGULATION OF THE DE NOVO SERINE AND GLYCINE PATHWAY IS A NOVEL THERAPEUTIC TARGET FOR GROUP 3 MYC-AMPLIFIED MEDULLOBLASTOMA
    Adiamah, Magretta
    Lindsey, Janet C.
    Burte, Florence
    Kohe, Sarah
    Morcavallo, Alaide
    Blair, Helen
    Hill, Rebecca M.
    Singh, Mankaran
    Crosier, Stephen
    Zhang, Tong
    Maddocks, Oliver
    Peet, Andrew
    Chesler, Louis
    Hickson, Ian
    Maxwell, Ross
    Clifford, Steven C.
    NEURO-ONCOLOGY, 2022, 24 : 125 - 125
  • [44] CASEIN KINASE 2 REGULATES EXPRESSION AND ACTIVITY OF MYC IN GROUP 3 MEDULLOBLASTOMA
    Jin, Benjamin
    Nitta, Ryan
    Li, Gordon
    NEURO-ONCOLOGY, 2016, 18 : 150 - 150
  • [45] TARGETING MYC AND OTX2-DRIVEN TRANSCRIPTIONAL DEPENDENCIES OF GROUP 3 MEDULLOBLASTOMA THROUGH CDK7 INHIBITION
    Zhang, Lei
    Li, Meng
    Hou, Linjun
    Zhang, Liye
    Tang, Yujie
    NEURO-ONCOLOGY, 2019, 21 : 104 - 104
  • [46] IDENTIFICATION OF NOVEL EPIGENETIC DRUG COMBINATIONS WITH SYNERGISTIC INHIBITORY EFFECTS AGAINST MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA
    Zhang, Lei
    Li, Meng
    Sui, Yi
    Liu, Fang
    Jiang, Wenyan
    Li, Tiantian
    Tang, Yujie
    NEURO-ONCOLOGY, 2017, 19 : 193 - 193
  • [47] Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression
    Mahlknecht, U
    Will, J
    Varin, A
    Hoelzer, D
    Herbein, G
    JOURNAL OF IMMUNOLOGY, 2004, 173 (06): : 3979 - 3990
  • [48] HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
    Till Milde
    Marco Lodrini
    Larissa Savelyeva
    Andrey Korshunov
    Marcel Kool
    Lena M. Brueckner
    André S. L. M. Antunes
    Ina Oehme
    Arnulf Pekrun
    Stefan M. Pfister
    Andreas E. Kulozik
    Olaf Witt
    Hedwig E. Deubzer
    Journal of Neuro-Oncology, 2012, 110 : 335 - 348
  • [49] HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
    Milde, Till
    Lodrini, Marco
    Savelyeva, Larissa
    Korshunov, Andrey
    Kool, Marcel
    Brueckner, Lena M.
    Antunes, Andre S. L. M.
    Oehme, Ina
    Pekrun, Arnulf
    Pfister, Stefan M.
    Kulozik, Andreas E.
    Witt, Olaf
    Deubzer, Hedwig E.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 110 (03) : 335 - 348
  • [50] Targeting Y box binding protein 1 (YBX1) in MYC-amplified medulloblastoma
    Carney, Stephen
    Hemenway, John
    Rajendran, Ashmitha
    Hathaway, Matt
    Nealy, Eric
    Bonatto, Christian
    Tailor, Dhanir
    Malhotra, Sanjay
    Evans, Myron
    CANCER RESEARCH, 2024, 84 (06)
12345